β-Lapachone has been generally known for antitumor agents and the effects on anti-inflammatory, anti-bacterial, anti-fungal, anti-obesity and anti-diabetic has been reparted recently. This study was designed to figure out the inhibitory mechanism of ...
β-Lapachone has been generally known for antitumor agents and the effects on anti-inflammatory, anti-bacterial, anti-fungal, anti-obesity and anti-diabetic has been reparted recently. This study was designed to figure out the inhibitory mechanism of β-Lapachone on melanogenesis. β-Lapachone inhibited melanin synthesis and tyrosinase activity at 0.8μM in melan-a melanocytes. But β-Lapachone did not inhibit mushroom tyrosinase activity and cell tyrosinase activity from Melan-a melanocyte directly. β-Lapachone also reduced the pigmentation of Melanoderm tissue at 40 μM. β-Lapachone inhibited α-glucosidase activity dose dependently (IC50 18.1 μM) but did not affect forming of immature tyrosinase. The expression of tyrosinase and tyrosinase-related protein-1 (TRP-1) were reduced by β-Lapachone at transcriptional and translational level. MITF protein level was also downregulated by β-Lapachone. The decreased expression of tyrosinase and TRP-1 might be resulted from the reduced MITF (Microphthalmia-associated trascription factor) which regulates major melanogenic proteins. Becuase the mRNA level of MITF was not changed by β-Lapachone treatment, we checked the effect of β-Lapachone on ERK phosphorylate which has been reported to regulated MITF degradation. The reduced level of MITF was associated with delayed ERK activation by β-Lapachone. These results show that β-Lapachone may be useful as a potential depigmenting agent for various hyperpigmentary disorders.